Search research articles
Contact Us
Filters
Showing results (1-10 of 30) with videos related to
Page
of 3
Sort By:
Clinical Journal of Oncology Nursing
|
September 29, 2011
Practical management of imatinib in gastrointestinal stromal tumors
Tamara Barnes, Denise Reinke
Clinical Journal of Oncology Nursing
|
August 29, 2007
A review of anemia management in the oncology setting: a focus on implementing standing orders
Jon Mickle, Denise Reinke
JAMA Oncology
|
July 10, 2020
Cancer Survivorship-Considering Mindsets-Reply
Laurence H Baker, Erin Peregrine Antalis, Denise Reinke
Oncology Nursing Forum
|
June 22, 2019
Patient Perceptions of Survivorship Care Plans: A Mixed-Methods Evaluation
Erin P Antalis, Rylee Doucette, Gielle Kuhn, et al.
Cancers
|
February 25, 2022
Global Patient Involvement in Sarcoma Care-A Collaborative Initiative of the Connective Tissue Oncology Society (CTOS) & Sarcoma Patients EuroNet (SPAEN)
Bernd Kasper, Kathrin Schuster, Roger Wilson, et al.
Medrxiv : the Preprint Server for Health Sciences
|
April 29, 2025
Measured intrapatient radiomic variability as a predictor of treatment response in multi-metastatic soft tissue sarcoma patients
Caryn Geady, James J Bannon, Shagheyegh Reza, et al.
Scientific Reports
|
July 30, 2025
Measured intrapatient radiomic variability as a predictor of treatment response in multi-metastatic soft tissue sarcoma patients
Caryn Geady, James J Bannon, Shagheyegh Reza, et al.
The Oncologist
|
February 25, 2012
Phase II study of sequential gemcitabine followed by docetaxel for recurrent Ewing sarcoma, osteosarcoma, or unresectable or locally recurrent chondrosarcoma: results of Sarcoma Alliance for Research Through Collaboration Study 003
Elizabeth Fox, Shreyaskumar Patel, J Kyle Wathen, et al.
Journal of Geriatric Oncology
|
May 26, 2019
Subgroup analysis of older patients treated within the randomized phase 3 doxorubicin versus doxorubicin plus evofosfamide (SARC021) trial
Eugenie Younger, Karla Ballman, Yao Lu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 23, 2016
Response to Early Treatment Evaluated with 18F-FDG PET and PERCIST 1.0 Predicts Survival in Patients with Ewing Sarcoma Family of Tumors Treated with a Monoclonal Antibody to the Insulinlike Growth Factor 1 Receptor
Joo Hyun O, Brandon S Luber, Jeffrey P Leal, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 30) with videos related to
Sort By:
Page
of 3
Clinical Journal of Oncology Nursing
|
September 29, 2011
Practical management of imatinib in gastrointestinal stromal tumors
Tamara Barnes, Denise Reinke
Clinical Journal of Oncology Nursing
|
August 29, 2007
A review of anemia management in the oncology setting: a focus on implementing standing orders
Jon Mickle, Denise Reinke
JAMA Oncology
|
July 10, 2020
Cancer Survivorship-Considering Mindsets-Reply
Laurence H Baker, Erin Peregrine Antalis, Denise Reinke
Oncology Nursing Forum
|
June 22, 2019
Patient Perceptions of Survivorship Care Plans: A Mixed-Methods Evaluation
Erin P Antalis, Rylee Doucette, Gielle Kuhn, et al.
Cancers
|
February 25, 2022
Global Patient Involvement in Sarcoma Care-A Collaborative Initiative of the Connective Tissue Oncology Society (CTOS) & Sarcoma Patients EuroNet (SPAEN)
Bernd Kasper, Kathrin Schuster, Roger Wilson, et al.
Medrxiv : the Preprint Server for Health Sciences
|
April 29, 2025
Measured intrapatient radiomic variability as a predictor of treatment response in multi-metastatic soft tissue sarcoma patients
Caryn Geady, James J Bannon, Shagheyegh Reza, et al.
Scientific Reports
|
July 30, 2025
Measured intrapatient radiomic variability as a predictor of treatment response in multi-metastatic soft tissue sarcoma patients
Caryn Geady, James J Bannon, Shagheyegh Reza, et al.
The Oncologist
|
February 25, 2012
Phase II study of sequential gemcitabine followed by docetaxel for recurrent Ewing sarcoma, osteosarcoma, or unresectable or locally recurrent chondrosarcoma: results of Sarcoma Alliance for Research Through Collaboration Study 003
Elizabeth Fox, Shreyaskumar Patel, J Kyle Wathen, et al.
Journal of Geriatric Oncology
|
May 26, 2019
Subgroup analysis of older patients treated within the randomized phase 3 doxorubicin versus doxorubicin plus evofosfamide (SARC021) trial
Eugenie Younger, Karla Ballman, Yao Lu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 23, 2016
Response to Early Treatment Evaluated with 18F-FDG PET and PERCIST 1.0 Predicts Survival in Patients with Ewing Sarcoma Family of Tumors Treated with a Monoclonal Antibody to the Insulinlike Growth Factor 1 Receptor
Joo Hyun O, Brandon S Luber, Jeffrey P Leal, et al.
Page
of 3